Screener
Immix Biopharma, Inc. IMMX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | 2026 / For the Three Months Ended / March 31, | 2025 / For the Three Months Ended / March 31, |
|---|---|---|
| Prepaid expenses and other current assets | (866,595) | (316,622) |
| Accounts payable and accrued expenses | 432,207 | 258,718 |
| Operating lease liability | (35,229) | (15,827) |
| Net cash used in operating activities | (9,827,193) | (1,685,140) |
| Investing Activities: | ||
| Purchase of property and equipment | (32,486) | (67,713) |
| Proceeds from the sale of short-term investments | 3,000,000 | - |
| Purchase of short-term investments | (7,768,350) | - |
Document
FAQ
- What is Immix Biopharma, Inc.'s operating cash flow?
- Immix Biopharma, Inc. (IMMX) reported operating cash flow of -$9.83M in Q1 2026.
- How has Immix Biopharma, Inc.'s operating cash flow changed year-over-year?
- Immix Biopharma, Inc.'s operating cash flow decreased by 483.2% year-over-year, from -$1.69M to -$9.83M.
- What is the long-term trend for Immix Biopharma, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s operating cash flow has grown at a 97.0% compound annual growth rate (CAGR), from -$1.59M to -$23.93M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Immix Biopharma, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude